This work was funded by BBSRC/EPSRC grant E021611. We thank Daiichi Sankyo Co. Ltd for funding (D.F.) and for strain SANK73390, and Dr. C. P. Butts for assistance with NMR analysis. MRSA=methicillin-resistant Staphylococcus aureus.
Engineered Thiomarinol Antibiotics Active against MRSA Are Generated by Mutagenesis and Mutasynthesis of Pseudoalteromonas SANK73390†
Version of Record online: 4 MAR 2011
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Angewandte Chemie International Edition
Volume 50, Issue 14, pages 3271–3274, March 28, 2011
How to Cite
Murphy, A. C., Fukuda, D., Song, Z., Hothersall, J., Cox, R. J., Willis, C. L., Thomas, C. M. and Simpson, T. J. (2011), Engineered Thiomarinol Antibiotics Active against MRSA Are Generated by Mutagenesis and Mutasynthesis of Pseudoalteromonas SANK73390. Angew. Chem. Int. Ed., 50: 3271–3274. doi: 10.1002/anie.201007029
- Issue online: 22 MAR 2011
- Version of Record online: 4 MAR 2011
- Manuscript Revised: 17 JAN 2011
- Manuscript Received: 9 NOV 2010
- BBSRC/EPSRC. Grant Number: E021611
Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.